Develops innovative cancer immunotherapies and vaccines using viral vector technology to target multiple tumor antigens and boost immune response
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Nouscom is a private oncology company developing next-generation immunotherapies, including off-the-shelf and personalized cancer vaccines. Their proprietary viral vector platform encodes multiple tumor neoantigens, aiming to induce broad and potent anti-tumor T cell responses.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Nouscom Management Team
Nouscom Valuations & Financials
View real-time NPM data on Nouscom stock including daily Nouscom stock price estimates, valuation history, and historical share price information. Access Nouscom financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Nouscom pricing across six independent market signals. Looking for private company due diligence data sources on Nouscom? Get in touch to learn more.
Similar Companies
like Nouscom
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Clarium Health
Healthcare & Life Sciences
Enhances hospital supply chains by integrating real-time data and automating workflows for improved efficiency.
Caxe
Fintech company develops AI-powered solutions for credit decisioning, digital banking, risk management, and regulatory compliance
Nooks
AI & Machine Learning
Accelerates prospect discovery and outreach by automating dialing, research, and coaching with AIpowered sales assistants.
Neeve
Delivers an edge cloud platform for secure, automated, and optimized management of smart building operations and OT systems.
Aethero
Industrials
Launches edge AI computers that process satellite data autonomously and compress bandwidth directly aboard spacecraft.
D-Tools
Provides unified software solutions that streamline sales, design, and project management for electronic systems contractors.
Selkirk Pharma
Healthcare & Life Sciences
Contract manufacturer specializing in sterile injectable drug production, offering fill/finish services and clinical trial material manufacturing.
Syndeio Biosciences
Pioneers precision neurotherapeutics that restore brain health by strengthening neural connections for neuropsychiatric and cognitive disorders.
FAQ
We have answers
Nouscom stock does not trade on public stock exchanges. Nouscom stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Nouscom stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Nouscom Stock does not trade on public stock exchanges. In order to sell Nouscom shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Nouscom does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Nouscom share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Nouscom stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Nouscom stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Nouscom stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Nouscom is a private company and has not had an IPO. There is currently no Nouscom IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Nouscom IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
